Showing 1 - 12 results of 12 for search 'Robert J Moots', query time: 0.05s Refine Results
  1. 1
    Rheumatology in India: Yesterday, today, and tomorrow?

    Rheumatology in India: Yesterday, today, and tomorrow? by Robert J Moots

    Published 2019-01-01
    Get full text
    Article
  2. 2
    Motherhood and fatherhood of patients with inflammatory rheumatic diseases in the era of biologics. Where are we after 20 years of anti-TNFs’ use?

    Motherhood and fatherhood of patients with inflammatory rheumatic diseases in the era of biologics. Where are we after 20 years of anti-TNFs’ use? by Robert J. Moots, Anna Felis-Giemza

    Published 2015-12-01
    Get full text
    Article
  3. 3
    Rheumatoid Arthritis Synovial Fluid Neutrophils Drive Inflammation Through Production of Chemokines, Reactive Oxygen Species, and Neutrophil Extracellular Traps

    Rheumatoid Arthritis Synovial Fluid Neutrophils Drive Inflammation Through Production of Chemokines, Reactive Oxygen Species, and Neutrophil Extracellular Traps by Helen L. Wright, Max Lyon, Elinor A. Chapman, Robert J. Moots, Robert J. Moots, Steven W. Edwards, Steven W. Edwards

    Published 2021-01-01
    Get full text
    Article
  4. 4
    RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming.

    RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming. by Helen L Wright, Huw B Thomas, Robert J Moots, Steven W Edwards

    Published 2013-01-01
    Get full text
    Article
  5. 5
    Whose Gene Is It Anyway? The Effect of Preparation Purity on Neutrophil Transcriptome Studies.

    Whose Gene Is It Anyway? The Effect of Preparation Purity on Neutrophil Transcriptome Studies. by Huw B Thomas, Robert J Moots, Steven W Edwards, Helen L Wright

    Published 2015-01-01
    Get full text
    Article
  6. 6
    Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus by Elinor A. Chapman, Max Lyon, Deborah Simpson, Deborah Simpson, David Mason, David Mason, Robert J. Beynon, Robert J. Beynon, Robert J. Moots, Robert J. Moots, Helen L. Wright

    Published 2019-03-01
    Get full text
    Article
  7. 7
    Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis

    Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis by Peter C. Taylor, Bryan Downie, Ling Han, Rachael Hawtin, Angie Hertz, Robert J. Moots, Tsutomu Takeuchi

    Published 2024-07-01
    Get full text
    Article
  8. 8
    Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT

    Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT by Robert J Moots, Farida Fortune, Richard Jackson, Tony Thornburn, Ann W Morgan, Dan Carr, Philip Ian Murray, Graham Robert Wallace, Deva Situnayake

    Published 2024-10-01
    Get full text
    Article
  9. 9
    Metabolic Profiling of Rheumatoid Arthritis Neutrophils Reveals Altered Energy Metabolism That Is Not Affected by JAK Inhibition

    Metabolic Profiling of Rheumatoid Arthritis Neutrophils Reveals Altered Energy Metabolism That Is Not Affected by JAK Inhibition by Susama Chokesuwattanaskul, Michele Fresneda Alarcon, Sangeetha Mangalakumaran, Rudi Grosman, Andrew L. Cross, Elinor A. Chapman, David Mason, Robert J. Moots, Marie M. Phelan, Helen L. Wright

    Published 2022-07-01
    Get full text
    Article
  10. 10
    Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis

    Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis by Sizheng Steven Zhao, Kazuki Yoshida, Gareth T. Jones, David M. Hughes, Stephen J. Duffield, Sara K. Tedeschi, Houchen Lyu, Robert J. Moots, Daniel H. Solomon, Nicola J. Goodson

    Published 2019-07-01
    Get full text
    Article
  11. 11
    Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.

    Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Res... by Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Mustafa H Al-Maini, Karel Pavelka, Ehab Mahgoub, Sameer Kotak, Joan Korth-Bradley, Ron Pedersen, Linda Mele, Qi Shen, Bonnie Vlahos

    Published 2017-01-01
    Get full text
    Article
  12. 12
    Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry

    Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry... by Alexandre Dumusc, Wan-Fai Ng, Katherine James, Bridget Griffiths, Elizabeth Price, Colin T. Pease, Paul Emery, Peter Lanyon, Adrian Jones, Michele Bombardieri, Nurhan Sutcliffe, Costantino Pitzalis, Monica Gupta, John McLaren, Annie Cooper, Ian Giles, David Isenberg, Vadivelu Saravanan, David Coady, Bhaskar Dasgupta, Neil McHugh, Steven Young-Min, Robert J. Moots, Nagui Gendi, Mohammed Akil, Francesca Barone, Benjamin A. Fisher, Saaeha Rauz, Andrea Richards, Simon J. Bowman, Swiss Medical Weekly

    Published 2018-02-01
    Get full text
    Article

Search Tools: